BlackRock’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.6M Buy
3,133,541
+9,357
+0.3% +$78.5K ﹤0.01% 2855
2025
Q4
$23.2M Buy
3,124,184
+55,236
+2% +$397K ﹤0.01% 3015
2025
Q3
$20.5M Sell
3,068,948
-67,721
-2% -$470K ﹤0.01% 3079
2025
Q2
$20.8M Buy
3,136,669
+306,147
+11% +$2.17M ﹤0.01% 3000
2025
Q1
$25.9M Buy
2,830,522
+37,573
+1% +$375K ﹤0.01% 2785
2024
Q4
$29.3M Buy
2,792,949
+120,689
+5% +$1.43M ﹤0.01% 2798
2024
Q3
$31.9M Buy
2,672,260
+300,879
+13% +$2.6M ﹤0.01% 2746
2024
Q2
$13.6M Buy
2,371,381
+1,838,568
+345% +$10.1M ﹤0.01% 3204
2024
Q1
$2.77M Buy
532,813
+27,239
+5% +$133K ﹤0.01% 3885
2023
Q4
$2.66M Sell
505,574
-1,460
-0.3% -$5.78K ﹤0.01% 3927
2023
Q3
$1.67M Buy
507,034
+37,955
+8% +$133K ﹤0.01% 4069
2023
Q2
$1.36M Sell
469,079
-1,472,251
-76% -$2.83M ﹤0.01% 4209
2023
Q1
$2.08M Sell
1,941,330
-266,186
-12% -$509K ﹤0.01% 4043
2022
Q4
$5.76M Buy
2,207,516
+56,196
+3% +$245K ﹤0.01% 3663
2022
Q3
$15.1M Buy
2,151,320
+151,471
+8% +$1.19M ﹤0.01% 3196
2022
Q2
$13.6M Buy
1,999,849
+216,762
+12% +$2.21M ﹤0.01% 3327
2022
Q1
$25.1M Sell
1,783,087
-31,945
-2% -$428K ﹤0.01% 3023
2021
Q4
$26.3M Buy
1,815,032
+1,081,692
+148% +$15.4M ﹤0.01% 3111
2021
Q3
$10.4M Buy
733,340
+293,206
+67% +$4.51M ﹤0.01% 3655
2021
Q2
$7.75M Buy
440,134
+48,308
+12% +$778K ﹤0.01% 3736
2021
Q1
$5.99M Buy
+391,826
New +$5.58M ﹤0.01% 3856

Other funds holding BVS